145 related articles for article (PubMed ID: 25215445)
1. Significant impact of behavioral and cognitive impairment on quality of life in patients with myotonic dystrophy type 1.
Rakocevic-Stojanovic V; Peric S; Madzarevic R; Dobricic V; Ralic V; Ilic V; Basta I; Nikolic A; Stefanova E
Clin Neurol Neurosurg; 2014 Nov; 126():76-81. PubMed ID: 25215445
[TBL] [Abstract][Full Text] [Related]
2. Influence of multisystemic affection on health-related quality of life in patients with myotonic dystrophy type 1.
Peric S; Stojanovic VR; Basta I; Peric M; Milicev M; Pavlovic S; Lavrnic D
Clin Neurol Neurosurg; 2013 Mar; 115(3):270-5. PubMed ID: 22695270
[TBL] [Abstract][Full Text] [Related]
3. Quality of life in patients with myotonic dystrophy type 2.
Rakocevic Stojanovic V; Peric S; Paunic T; Pesovic J; Vujnic M; Peric M; Nikolic A; Lavrnic D; Savic Pavicevic D
J Neurol Sci; 2016 Jun; 365():158-61. PubMed ID: 27206898
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid biomarkers of neurodegeneration in patients with juvenile and classic myotonic dystrophy type 1.
Peric S; Mandic-Stojmenovic G; Markovic I; Stefanova E; Ilic V; Parojcic A; Misirlic-Dencic S; Ostojic M; Rakocevic-Stojanovic V; Kostic V
Eur J Neurol; 2014 Feb; 21(2):231-7. PubMed ID: 23834502
[TBL] [Abstract][Full Text] [Related]
5. Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study.
Baldanzi S; Bevilacqua F; Lorio R; Volpi L; Simoncini C; Petrucci A; Cosottini M; Massimetti G; Tognoni G; Ricci G; Angelini C; Siciliano G
Orphanet J Rare Dis; 2016 Apr; 11():34. PubMed ID: 27044540
[TBL] [Abstract][Full Text] [Related]
6. Quality of life and subjective symptom impact in Japanese patients with myotonic dystrophy type 1.
Fujino H; Saito T; Takahashi MP; Takada H; Nakayama T; Imura O; Matsumura T
BMC Neurol; 2022 Feb; 22(1):55. PubMed ID: 35164706
[TBL] [Abstract][Full Text] [Related]
7. Cognitive impairment in myotonic dystrophy type 1 is associated with white matter damage.
Caso F; Agosta F; Peric S; Rakočević-Stojanović V; Copetti M; Kostic VS; Filippi M
PLoS One; 2014; 9(8):e104697. PubMed ID: 25115999
[TBL] [Abstract][Full Text] [Related]
8. Dependent and paranoid personality patterns in myotonic dystrophy type 1.
Peric S; Sreckov M; Basta I; Lavrnic D; Vujnic M; Marjanovic I; Rakocevic Stojanovic V
Acta Neurol Scand; 2014 Apr; 129(4):219-25. PubMed ID: 24032453
[TBL] [Abstract][Full Text] [Related]
9. Differences in the pattern of cognitive impairments between juvenile and adult onset myotonic dystrophy type 1.
Woo J; Lee HW; Park JS
J Clin Neurosci; 2019 Oct; 68():92-96. PubMed ID: 31371188
[TBL] [Abstract][Full Text] [Related]
10. Prospective measurement of quality of life in myotonic dystrophy type 1.
Peric S; Heatwole C; Durovic E; Kacar A; Nikolic A; Basta I; Marjanovic A; Stevic Z; Lavrnic D; Rakocevic Stojanovic V
Acta Neurol Scand; 2017 Dec; 136(6):694-697. PubMed ID: 28660733
[TBL] [Abstract][Full Text] [Related]
11. Fatigue and daytime sleepiness in patients with myotonic dystrophy type 1: to lump or split?
Laberge L; Dauvilliers Y; Bégin P; Richer L; Jean S; Mathieu J
Neuromuscul Disord; 2009 Jun; 19(6):397-402. PubMed ID: 19403309
[TBL] [Abstract][Full Text] [Related]
12. Cognitive impairment and quality of life in patients with myotonic dystrophy type 1.
Fujino H; Shingaki H; Suwazono S; Ueda Y; Wada C; Nakayama T; Takahashi MP; Imura O; Matsumura T
Muscle Nerve; 2018 May; 57(5):742-748. PubMed ID: 29193182
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life in myotonic dystrophy type 1 and its relationship with cognitive and emotional functioning.
Antonini G; Soscia F; Giubilei F; De Carolis A; Gragnani F; Morino S; Ruberto A; Tatarelli R
J Rehabil Med; 2006 May; 38(3):181-5. PubMed ID: 16702085
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in adult patients with limb-girdle muscular dystrophies.
Peric M; Peric S; Stevanovic J; Milovanovic S; Basta I; Nikolic A; Kacar A; Rakocevic-Stojanovic V
Acta Neurol Belg; 2018 Jun; 118(2):243-250. PubMed ID: 29116571
[TBL] [Abstract][Full Text] [Related]
15. Frontostriatal dysexecutive syndrome: a core cognitive feature of myotonic dystrophy type 2.
Peric S; Mandic-Stojmenovic G; Stefanova E; Savic-Pavicevic D; Pesovic J; Ilic V; Dobricic V; Basta I; Lavrnic D; Rakocevic-Stojanovic V
J Neurol; 2015 Jan; 262(1):142-8. PubMed ID: 25346064
[TBL] [Abstract][Full Text] [Related]
16. Multidimensional aspects of pain in myotonic dystrophies.
Peric M; Peric S; Rapajic N; Dobricic V; Savic-Pavicevic D; Nesic I; Radojicic S; Novakovic I; Lavrnic D; Rakocevic-Stojanovic V
Acta Myol; 2015 Dec; 34(2-3):126-32. PubMed ID: 27199540
[TBL] [Abstract][Full Text] [Related]
17. Disease burden of myotonic dystrophy type 1.
Landfeldt E; Nikolenko N; Jimenez-Moreno C; Cumming S; Monckton DG; Gorman G; Turner C; Lochmüller H
J Neurol; 2019 Apr; 266(4):998-1006. PubMed ID: 30788616
[TBL] [Abstract][Full Text] [Related]
18. The proposal of a clinical protocol to assess central and peripheral fatigue in myotonic dystrophy type 1.
Baldanzi S; Ricci G; Bottari M; Chico L; Simoncini C; Siciliano G
Arch Ital Biol; 2017 Jul; 155(1-2):43-53. PubMed ID: 28715597
[TBL] [Abstract][Full Text] [Related]
19. Fatigue and daytime sleepiness scale in myotonic dystrophy type 1.
Hermans MC; Merkies IS; Laberge L; Blom EW; Tennant A; Faber CG
Muscle Nerve; 2013 Jan; 47(1):89-95. PubMed ID: 23042586
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life in patients with myotonic dystrophy type 1 and amyotrophic lateral sclerosis.
Peric' S; Rakocevic-Stojanovic V; Stevic Z; Basta I; Pavlovic S; Vujanac V; Marjanovic L; Lavrnic D
Acta Neurol Belg; 2010 Mar; 110(1):71-7. PubMed ID: 20514929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
